Peptable

Comparison

Setmelanotide vs Tesamorelin

Function

While Setmelanotide is approved for chronic weight management in patients with POMC, PCSK1, LEPR deficiencies and Bardet–Biedl syndrome by reducing hunger and promoting weight loss92, Tesamorelin is FDA-approved to reduce excess visceral adipose tissue in HIV-associated lipodystrophy and is studied for broader body-composition, NAFLD, and cognitive effects via GH/IGF-1 axis modulation1893.

Mechanism

While Setmelanotide works as a potent synthetic melanocortin-4 receptor (MC4R) agonist derived from a POMC/α-MSH–related sequence that restores downstream MC4R signaling in genetic obesity syndromes3192100, Tesamorelin is a full-length 44-amino-acid GHRH analog with an N-terminal trans-3-hexenoic acid modification that binds GHRHR, activating cAMP/PKA signaling to increase endogenous GH and IGF-1, with improved stability versus native GHRH182893102.

Receptor

Setmelanotide

Melanocortin-4 receptor (MC4R) 3192100

Tesamorelin

Growth hormone–releasing hormone receptor (GHRHR) 9394103

Organism or Origin

Setmelanotide

Synthetic analog of POMC-derived α-MSH peptide928190

Tesamorelin

Synthetic analog of human hypothalamic GHRH1893

Gene

Setmelanotide

POMC

Tesamorelin

GHRH

Summary

Both peptides fall into a similar broad context as Metabolic peptides, although the details of how they are used and discussed still diverge. Both are often discussed in Metabolic and endocrine contexts, while Setmelanotide is more of a neuropeptide and Tesamorelin is better described as a hormone peptide. Both appear to work through Receptor agonist, but the functional emphasis still separates, with Setmelanotide leaning toward Metabolic regulation and Lipolysis and fat loss and Tesamorelin leaning toward Anabolic growth. Setmelanotide has a more synthetic design origin, while Tesamorelin is closer to synthetic analog background. Setmelanotide takes the form of a cyclic peptide, whereas Tesamorelin is closer to a peptide conjugate, Setmelanotide carries d-amino acid substitution features, while Tesamorelin instead reflects amidation changes; while their sequence patterns also diverge, with Setmelanotide showing protein-mimetic sequence features and Tesamorelin showing alpha-helical domain features.

Related articles

No related articles are linked to these peptides yet.

Sources

31[PDF] 213793Orig1s000 - accessdata.fda.gov, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213793Orig1s000PharmR.pdf
81Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC2253185/
90alpha-Melanocyte stimulating hormone: production and degradation, https://pmc.ncbi.nlm.nih.gov/articles/PMC3936413/
92Setmelanotide, https://go.drugbank.com/drugs/DB11700
100Multiple Independent Sub-studies of Setmelanotide in, https://onderzoekmetmensen.nl/en/node/53452/pdf
18Tesamorelin: Benefits, Dosing & Where to Buy (2026) - Peptides, https://thepeptidecatalog.com/peptides/tesamorelin
28The Ultimate Guide to Tesamorelin | Las Vegas | Sky Health, https://www.skyhealthnv.com/tesamorelin
93Tesamorelin - FDA-Approved GHRH Analog Guide - PeptideMark, https://www.peptidemark.com/peptides/tesamorelin
94Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth-hormone-releasing_hormone_receptor
102Tesamorelin: Molecular Characterization and Metabolic Research, https://biotechpeptides.com/2026/03/25/tesamorelin-molecular-characterization-growth-hormone-axis-modulation-and-metabolic-research/
103Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth_hormone_releasing_hormone_receptor